CA982478A - Orally administered drug composition for therapy in the treatment of narcotic drug addiction - Google Patents

Orally administered drug composition for therapy in the treatment of narcotic drug addiction

Info

Publication number
CA982478A
CA982478A CA139,081A CA139081A CA982478A CA 982478 A CA982478 A CA 982478A CA 139081 A CA139081 A CA 139081A CA 982478 A CA982478 A CA 982478A
Authority
CA
Canada
Prior art keywords
therapy
treatment
orally administered
narcotic
addiction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA139,081A
Other versions
CA139081S (en
Inventor
Jerome Berk
Irving F. Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WEST LABORATORIES
Original Assignee
WEST LABORATORIES
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WEST LABORATORIES filed Critical WEST LABORATORIES
Application granted granted Critical
Publication of CA982478A publication Critical patent/CA982478A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
CA139,081A 1971-04-12 1972-04-06 Orally administered drug composition for therapy in the treatment of narcotic drug addiction Expired CA982478A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13334471A 1971-04-12 1971-04-12

Publications (1)

Publication Number Publication Date
CA982478A true CA982478A (en) 1976-01-27

Family

ID=22458150

Family Applications (1)

Application Number Title Priority Date Filing Date
CA139,081A Expired CA982478A (en) 1971-04-12 1972-04-06 Orally administered drug composition for therapy in the treatment of narcotic drug addiction

Country Status (4)

Country Link
CA (1) CA982478A (en)
DE (1) DE2217132A1 (en)
FR (1) FR2132856B1 (en)
GB (1) GB1378348A (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8307096A1 (en) * 1981-06-01 1983-07-01 Orion Yhtymae Oy Tablets which do not damage the oesophagus.
NL8400911A (en) * 1984-03-22 1985-10-16 Dagra Nv PROCESS FOR PREPARING A PHARMACEUTICAL FORM OF ADMINISTRATION CONTAINING TETRACYCLINE OR DOXYCYCLINE SALTS.
ES2435722T3 (en) 1997-09-04 2013-12-23 Demerx, Inc. Noribogaine in the treatment of pain and drug addiction
US7220737B1 (en) 1997-09-04 2007-05-22 Novoneuron, Inc Noribogaine in the treatment of pain and drug addiction
ITMI20041317A1 (en) * 2004-06-30 2004-09-30 Ibsa Inst Biochimique Sa PHARMACEUTICAL FORMULATIONS FOR THE SAFE ADMINISTRATION OF DRUGS USED IN THE TREATMENT OF DRUG ADDICTION AND PROCEDURE FOR THEIR OBTAINING
US9125867B2 (en) * 2010-02-24 2015-09-08 Invincible Biotechnology Diversion- and/or abuse-resistant compositions and methods for making the same
US8765737B1 (en) 2010-05-11 2014-07-01 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US9394294B2 (en) 2010-05-11 2016-07-19 Demerx, Inc. Methods and compositions for preparing and purifying noribogaine
US8362007B1 (en) 2010-05-11 2013-01-29 Demerx, Inc. Substituted noribogaine
US8741891B1 (en) 2010-06-22 2014-06-03 Demerx, Inc. N-substituted noribogaine prodrugs
US8637648B1 (en) 2010-06-22 2014-01-28 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
US9586954B2 (en) 2010-06-22 2017-03-07 Demerx, Inc. N-substituted noribogaine prodrugs
US8802832B2 (en) 2010-06-22 2014-08-12 Demerx, Inc. Compositions comprising noribogaine and an excipient to facilitate transport across the blood brain barrier
WO2012012764A1 (en) 2010-07-23 2012-01-26 Demerx, Inc. Noribogaine compositions
EP2481740B1 (en) 2011-01-26 2015-11-04 DemeRx, Inc. Methods and compositions for preparing noribogaine from voacangine
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
CA2855994A1 (en) 2011-12-09 2013-06-13 Demerx, Inc. Phosphate esters of noribogaine
CA2858820C (en) 2012-01-25 2021-08-17 Demerx, Inc. Synthetic voacangine
US9150584B2 (en) 2012-01-25 2015-10-06 Demerx, Inc. Indole and benzofuran fused isoquinuclidene derivatives and processes for preparing them
CA2896133A1 (en) 2012-12-20 2014-06-26 Demerx, Inc. Substituted noribogaine
US9045481B2 (en) 2012-12-20 2015-06-02 Demerx, Inc. Substituted noribogaine
US8940728B2 (en) 2012-12-20 2015-01-27 Demerx, Inc. Substituted noribogaine
CA2989550C (en) 2014-06-18 2023-08-08 Demerx, Inc. Halogenated indole and benzofuran derivatives of isoquinuclidene and processes for preparing them

Also Published As

Publication number Publication date
FR2132856A1 (en) 1972-11-24
FR2132856B1 (en) 1975-04-25
GB1378348A (en) 1974-12-27
DE2217132A1 (en) 1972-10-26

Similar Documents

Publication Publication Date Title
CA982478A (en) Orally administered drug composition for therapy in the treatment of narcotic drug addiction
CA942894A (en) Patient treatment table
AU470102B2 (en) Isomorphinan and morphinan derivatives and process for their preparation
AU4541772A (en) Propanolamine derivatives, their preparation and therapeutic compositions containing thesame
AU465949B2 (en) N-TERTIARY-4'-AMINOMETHYL-DIBENZO b,e-11-OXEPINE-2'-SPIRO-1',3'-DIOXOLANES, THEIR PROCESS OF PREPARATION AND THEIR THERAPEUTIC APPLICATION
GB1368201A (en) Treatment of diseases of the skin and mucosa
ZA71951B (en) Dosage units for the administration of medicaments and the like
CA931666A (en) Patient treatment table
AU472168B2 (en) Treatment of titanium
ZA742728B (en) Pharmaceutical composition for the treatment of coronaric ailments
CA987321A (en) Process of preparation and therapeutic application of substituted isopropyl-2-tetrahydro oxazines-1,3
CA989307A (en) Agent for the treatment of hyperlipoproteinemias and process for the preparation thereof
ZA724724B (en) Pharmaceutical compositions for treatment of bronchial diseases
CA1022099A (en) Process for the preparation of technical white oils and medicinal oils
AU426565B2 (en) Bandage for administering drugs
AU462834B2 (en) Pharmaceutical composition and method of treatment
CA988423A (en) Pharmaceutical preparation for percutaneous treatment of local edemas
ZA724296B (en) New medicants for the treatment of excess lipidic and cellulitic stresses
AU465312B2 (en) Method of administering vitamins
CA874950A (en) Method for the administration of medicaments and articles therefor
ZA74655B (en) Medicament for use in the treatment of cancer
CA868873A (en) Method of and pharmaceutical for the treatment of hyperazotemia
KE2621A (en) Pharmaceutical preparation and treatment
CA837050A (en) Method of and composition for the treatment of human carcinoma and hypercholestrolemia
AU458147B2 (en) Processes forthe preparation of dosage units in solid state for medicament